Zai Lab Announces Participation in March Investor Conference
March 06 2024 - 7:30AM
Business Wire
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that
members of the Company’s senior management team will participate in
the following investor conference in March 2024:
Leerink Partners Global Biopharma
Conference 2024 Presentation: Monday, March 11, 2024, 4:00 p.m.
ET Location: Fontainebleau, Miami Beach Room: Glimmer 3
A live webcast of the presentation will be available on the
Investor Relations page of Zai Lab’s website at
ir.zailaboratory.com/webcasts-presentations and an archived replay
will be available for up to 90 days following the completion of the
event.
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative,
research-based, commercial-stage biopharmaceutical company based in
China and the United States. We are focused on discovering,
developing, and commercializing innovative products that address
medical conditions with significant unmet needs in the areas of
oncology, autoimmune disorders, infectious diseases, and
neuroscience. Our goal is to leverage our competencies and
resources to positively impact human health in China and
worldwide.
For additional information about Zai Lab, please visit
www.zailaboratory.com or follow us at
www.twitter.com/ZaiLab_Global.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240306695050/en/
For more information:
Investor Relations: Christine Chiou / Lina Zhang
+1 (917) 886-6929 / +86 136 8257 6943
christine.chiou1@zailaboratory.com /
lina.zhang@zailaboratory.com
Media: Shaun Maccoun / Xiaoyu Chen +1 (415) 317-7255 /
+86 185 0015 5011 shaun.maccoun@zailaboratory.com /
xiaoyu.chen@zailaboratory.com
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From Jul 2024 to Aug 2024
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From Aug 2023 to Aug 2024